Construction and engineering company, Jacobs Engineering Group Inc. (JEC) has been achieving great success with its contract wins. Jacobs won yet another contract recently; this time from Tronox Limited (TROX); after gaining a contract from Bayer CropScience Pty Ltd in Australia earlier in the month.
The new contract relates to the early stage engineering for Tronox’s aluminum chloride generator at the pigment plant in Kwinana, Western Australia. The duration as well as financial value of the contract is kept undisclosed.
The contract involves the evaluation of various generator technologies. Subsequent to the evaluation, the technology will be installed at Tronox’s pigment sites in Kwinana; Hamilton, Mississippi US; and Botlek, Netherlands. After successfully fulfilling its commitment at Tronox’s Hamilton, Mississippi facility, Jacobs aims to attain success in implementing the work of the new contract as well.
Jacobs won another contract on the same day, from Marine Corps Logistics Command (:MCLC) and the Marine Corps operating forces. The project spans five years, with a maximum order limit of $855.0 million.
The scope of the project comprises support services in logistics, supply chain, distribution management, maintenance management, and strategic prepositioning capability. Jacobs is one of the nineteen companies selected to fulfill the requirements of the project.
This is not the first time Jacobs is providing its services to Tronox or Marine Corps. The re-association with these companies can be assumed to be a result of the successful implementation of Jacobs’ promises.
Jacobs is set to release its fiscal third quarter 2013 results on Jul 29, 2013. The Zacks Consensus Estimate stands at 84 cents, reflecting a year-over-year hike of 10.5%. The company’s long-term estimated earnings per share growth rate is 13.5%.
Jacobs currently carries a Zacks Rank #3 (Hold). Other stocks worth a watch in the industry are Beazer Homes USA Inc. (BZH) and Chicago Bridge & Iron Company N.V. (CBI) each carrying a Zacks Rank #2 (Buy).
More From Zacks.com